Role of cyclic AMP in the actions of cannabinoid receptors

Biochemical Pharmacology

Volumn 52, Issue 6, 1996, Pages 819-827

  Childers, S R ^a   Deadwyler, S A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

cyclic AMP; G proteins; K+ channels; protein kinase; 9 tetra hydrocannabinol

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); IP 20; ISOBUTYLMETHYLXANTHINE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; POTASSIUM CHANNEL; RADIOISOTOPE; UNCLASSIFIED DRUG;

BEHAVIOR; DRUG ACTIVITY; DRUG MECHANISM; DRUG RESPONSE; ENZYME INHIBITION; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; ION CONDUCTANCE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029778985     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00419-4     Document Type: Note

References (68)

1. AC Howlett Inhibition of neuroblastoma adenylyl cyclase by cannabinoid and nantradol compounds Life Sci 35 1984 1803 1810
2. Y Gaoni R Mechoulam Isolation, structure, and partial synthesis of an active constituent of hashish J Am Chem Soc 86 1964 1646 1647
3. BR Martin Cellular effects of cannabinoids Pharmacol Rev 38 1986 45 74
4. WL Dewey Cannabinoid pharmacology Pharmacol Rev 48 1986 151 174
5. CJ Hillard RA Harris AS Bloom Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescence studies J Pharmacol Exp Ther 232 1985 579 588
6. MR Johnson LS Melvin The discovery of nonclassical cannabinoid analgetics R Mechoulam Cannabinoids as Therapeutic Agents 1986 CRC Press Boca Raton 121 145
7. J Kuster J Stevenson S Ward T D'Ambra D Haycock Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids J Pharmacol Exp Ther 264 1993 1352 1363
8. M Pacheco SR Childers R Arnold F Casiano SJ Ward Aminoalkylindoles: Actions on specific G-protein-linked receptors J Pharmacol Exp Ther 257 1991 170 183
9. AC Howlett RM Fleming Cannabinoid inhibition of adenylate cyclase: Pharmacology of the response in neuroblastoma cell membranes Mol Pharmacol 26 1984 532 538
10. AC Howlett Cannabinoid inhibition of adenylate cyclase: Biochemistry of the response in neuroblastoma cell membranes Mol Pharmacol 27 1985 429 436
11. i in the inhibition of adenylate cyclase by cannabimimetic drugs Mol Pharmacol 29 1986 307 313
12. WA Devane FAI Dysarz MR Johnson LS Melvin AC Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613
13. M Herkenham AB Lynne MD Little MR Johnson LS Melvin BR de Costa KC Rice Cannabinoid receptor localization in brain Second Edition Proc Natl Acad Sci USA 87 1990 1932 1936
14. LA Matsuda SJ Lolait MJ Brownstein AL Young TI Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
15. WA Devane L Hanus A Breuer RG Pertwee LA Stevenson G Griffin D Gibson A Mandelbaum A Etinger R Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
16. S Munro KL Thomas M Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
17. AG Gilman G proteins: Transducers of receptor-generated signals Annu Rev Biochem 56 1987 615 649
18. L Birnbaumer J Abramowitz AM Brown Receptor effector coupling by G proteins Biochim Biophy Acta 1031 1990 163 224
19. T Asano SE Pedersen CW Scott EM Ross Reconstitution of catecholamine-stimulated binding of guanosine 5′- O -(3-thiotriphosphate) to the stimulatory GTP-binding protein of adenylate cyclase Biochemistry 23 1984 5460 5467
20. P Gierschik R Moghtader C Straub K Dieterich KH Jakobs Signal amplification in HL-60 granulocytes: Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes Eur J Biochem 197 1991 725 732
21. D Cassel Z Selinger Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes Biochim Biophys Acta 452 1976 538 551
22. G Koski WA Klee Opiates inhibit adenylate cyclase by stimulation of GTP hydrolysis Second Edition Proc Natl Acad Sci USA 78 1981 4185 4189
23. m GTPase studies J Pharmacol Exp Ther 263 1992 99 104
24. G Hilf P Gierschik KH Jakobs Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′- O -(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes Eur J Biochem 186 1989 725 731
25. 35 S]thio)triphosphate binding Mol Pharmacol 44 1993 115 123
26. S Lazareno T Farries NJM Birdsall Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors M1–M4 Life Sci 52 1993 449 456
27. 35 S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells Mol Pharmacol 47 1995 848 854
28. 35S]thio]-triphosphate binding Second Edition Proc Natl Acad Sci USA 92 1995 7242 7246
29. Sim LJ, Selley DE, Xiao R and Childers SR, Differences in G-protein activation by mu and delta opioid, and cannabinoid, receptors in rat striatum. Eur J Pharmacol , in press.
30. D Compton MR Johnson L Melvin BR Martin Pharmacological profile of a series of bicyclic cannabinoid analogues: Classification as cannabimimetic agents J Pharmacol Exp Ther 260 1992 201 209
31. BF Thomas DR Compton BR Martin SF Semus Modeling the cannabinoid receptor: A three-dimensional quantitative structure-activity analysis Mol Pharmacol 40 1991 656 665
32. DR Compton KC Rice BR De Costa RK Razdan LS Melvin MR Johnson BR Martin Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities J Pharmacol Exp Ther 265 1993 218 226
33. LS Melvin GM Milne MR Johnson B Subramaniam GH Wilken AC Howlett Structure-activity relationships for cannabinoid receptor binding and analgesic activity: Studies of bicyclic cannabinoid analogs Mol Pharmacol 44 1993 1008 1015
34. IB Adams W Ryan M Singer BF Thomas D Compton RK Razdan BR Martin Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs J Pharmacol Exp Ther 273 1995 1172 1181
35. BF Thomas IB Adams SW Mascarella BR Martin RK Razdan Structure-activity analysis of anandamide analogs: Relationship to a cannabinoid pharmacophore J Med Chem 39 1996 471 479
36. K Mackie B Hille Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells Second Edition Proc Natl Acad Sci USA 89 1992 3825 3829
37. MP Caulfield DA Brown Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism Br J Pharmacol 106 1992 231 232
38. K Mackie WA Devane B Hille Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells Mol Pharmacol 44 1993 498 503
39. Shen M, Piser TM, Seybold VS and Thayer SA, Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci , in press.
40. K Mackie Y Lai R Westenbroek R Mitchell Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor J Neurosci 15 1995 6552 6561
41. CA Audette SH Burstein SA Doyle SA Hunter G-protein mediation of cannabinoid-induced phospholipase activation Pharmacol Biochem Behav 40 1991 559 563
42. S Burstein J Budrow M Debatis SA Hunter A Subramanian Phospholipase participation in cannabinoid-induced release of free arachidonic acid Biochem Pharmacol 48 1994 1253 1264
43. 9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A Biochem Pharmacol 51 1996 669 676
44. DM Slipetz GP O'Neill L Favreau C Dufresne M Gallant Y Gareau D Guay M Labelle KM Metters Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase Mol Pharmacol 48 1995 352 361
45. 2 receptors Mol Pharmacol 48 1995 443 450
46. M Bayewitch T Avidor-Reiss R Levy J Barg R Mechoulam Z Vogel The peripheral cannabinoid receptor: Adenylate cyclase inhibition and G protein coupling FEBS Lett 375 1995 143 147
47. RG Pertwee G Joe-Adigwe GM Hawksworth Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens Eur J Pharmacol 296 1996 169 172
48. M Pacheco SJ Ward SR Childers Identification of cannabinoid receptors in cultures of rat cerebellar granule cells Brain Res 603 1993 102 110
49. MA Pacheco SJ Ward SR Childers Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes J Neurochem 62 1994 1773 1782
50. M Bidaut-Russell WA Devane AC Howlett Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain J Neurochem 55 1990 21 26
51. SR Childers T Sexton MB Roy Effects of anandamide on cannabinoid receptors in rat brain membranes Biochem Pharmacol 47 1994 711 715
52. 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes Life Sci 48 1991 1133 1141
53. M Rinaldi-Carmona F Barth M Heaulme D Shire B Calandra C Congy S Martinez J Maruani G Neliat D Caput P Ferrara P Soubrie JC Breliere G Le Fur SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 1994 240 244
54. B) receptors of cerebellum may share a common adenylate cyclase catalytic unit J Pharmacol Exp Ther 232 1985 62 66
55. B receptors to the same channels in hippocampus Science 234 1986 1261 1265
56. F Fan Q Tao M Abood BR Martin Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55, 940-tolerant mice Brain Res 706 1996 13 20
57. SA Deadwyler RE Hampson BA Bennett TA Edwards J Mu MA Pacheco SJ Ward SR Childers Cannabinoids modulate potassium current in cultured hippocampal neurons Receptors Channels 1 1993 121 134
58. SR Childers MA Pacheco BA Bennett TA Edwards RE Hampson J Mu SA Deadwyler Cannabinoid receptors: G-protein-mediated signal transduction mechanisms Second Edition Biochem Soc Symp 59 1993 27 50
59. SA Deadwyler RE Hampson J Mu A Whyte SR Childers Cannabinoids modulate voltage-sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process J Pharmacol Exp Ther 273 1995 734 743
60. RE Hampson GJO Evans J Mu S Zhuang VC King SR Childers SA Deadwyler Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium “A-current” in cultured rat hippocampal neurons Life Sci 56 1995 2081 2088
61. SA Deadwyler RE Hampson SR Childers Functional significance of cannabinoid receptors in brain RG Pertwee Cannabinoid Receptors 1995 Academic Press New York 206 231
62. J Mu RE Hampson S-Y Zhuang VC King SA Deadwyler SR141716A blocks cannabinoid modulation of potassium A-current in cultured hippocampal neurons Soc Neurosci Abstr 21 1995 1832
63. M Comb SE Hyman HM Goodman Mechanisms of trans-synaptic regulation of gene expression Trends Neurosci 10 1987 473 478
64. BW Kluttz KE Vrana SI Dworkin SR Childers Effects of morphine on forskolin-stimulated pro-enkephalin mRNA levels in rat striatum: A model for acute and chronic opioid actions in brain Mol Brain Res 32 1995 313 320
65. D Piomelli Arachidonic acid FE Bloom DJ Kupfer Psychopharmacology: The Fourth Generation of Progress 1995 Raven Press New York 595 607
66. H Cadas S Gaillet M Beltramo L Venance D Piomelli Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP J Neurosci 16 1996 3934 3942
67. JF Storm Potassium currents in hippocampal pyramidal cells Prog Brain Res 83 1990 161 187
68. 35S]GTPγS binding in rat brain membranes Life Sci 59 1996 659 668